Chiome Biosci 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CBA-1535 / Chiome Biosci
NCT07016997: A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.

Recruiting
1
70
Japan
CBA-1535, CBA-1535+Pembrolizumab
Chiome Bioscience Inc.
Solid Tumors, Refractory Cancer
12/25
12/26
20A77 / Chiome Biosci
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CBA-1535 / Chiome Biosci
NCT07016997: A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.

Recruiting
1
70
Japan
CBA-1535, CBA-1535+Pembrolizumab
Chiome Bioscience Inc.
Solid Tumors, Refractory Cancer
12/25
12/26
20A77 / Chiome Biosci
No trials found

Download Options